Interestingly, Hu et al. [101] demonstrated that engineered TGF-β CAR T cells engaged in shielding tumor targeting cells from TGF-β mediated immunosuppression concomitantly enhancing their antitumor function, and attenuated the differentiation into T reg cells. Here, TGFB1 is linked to neoplasm.